The data on global pancreas malignant neoplasms mortality highlights notable disparities across countries, with Hungary leading at 17.0 deaths per hundred thousand women, followed by Finland and the Czech Republic. Some countries like Israel and Iceland observed significant mortality increases, with growth rates of 2.08% and 3.93% year-on-year, respectively. Conversely, Argentina, Estonia, and Portugal showed declining trends. While the US reported a relatively steady rate, countries like Luxemburg and Japan saw noticeable upticks.
Looking forward, it is crucial to monitor countries with rising trends, like Japan and Israel, for potential policy and healthcare implications. Increased surveillance in regions with previously declining trends, such as Argentina, could provide insights into effective interventions. The global push for better detection and treatment technologies might further influence these rates in the coming years.
Top countries in Pancreas Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Hungary | 17 | 2023 | +0.59% | +1.22% | View data |
| 2 | 2 Finland | 15.8 | 2023 | 0% | -0.74% | View data |
| 3 | 3 Czech Republic | 15.7 | 2023 | 0% | -0.13% | View data |
| 4 | 4 Austria | 15.1 | 2023 | +0.67% | 0% | View data |
| 5 | 5 Japan | 15.1 | 2023 | +1.34% | +1.38% | View data |
| 6 | 6 Germany | 15.1 | 2023 | +0.67% | +0.81% | View data |
| 7 | 7 Sweden | 14.7 | 2023 | 0% | +0.14% | View data |
| 8 | 8 Latvia | 14.5 | 2023 | +1.4% | -0.41% | View data |
| 9 | 9 Estonia | 14.5 | 2023 | +1.4% | -1.2% | View data |
| 10 | 10 Israel | 14.3 | 2023 | +0.7% | +2.08% | View data |
